Assetmark, Inc Baxter International Inc Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Baxter International Inc stock. As of the latest transaction made, Assetmark, Inc holds 101,153 shares of BAX stock, worth $2.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

101,153

Previous 78,868 28.26%

Holding current value

$2.98 Million

Previous $2.64 Million 45.56%

% of portfolio

0.01%

Previous 0.01%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$32.85 - $40.26 $732,062 - $897,194	22,285 Added 28.26%	101,153 $3.84 Million
Q2 2024 Aug 13, 2024	SELL	$32.87 - $43.55 $20,379 - $27,001	-620 Reduced 0.78%	78,868 $2.64 Million
Q1 2024 May 06, 2024	SELL	$37.88 - $43.77 $42,387 - $48,978	-1,119 Reduced 1.39%	79,488 $3.4 Million
Q4 2023 Feb 09, 2024	SELL	$31.71 - $38.95 $16,457 - $20,215	-519 Reduced 0.64%	80,607 $3.12 Million
Q3 2023 Oct 27, 2023	BUY	$37.32 - $49.29 $325,019 - $429,266	8,709 Added 12.03%	81,126 $3.06 Million
Q2 2023 Aug 11, 2023	BUY	$39.98 - $47.68 $106,826 - $127,400	2,672 Added 3.83%	72,417 $3.3 Million
Q1 2023 May 05, 2023	BUY	$37.58 - $52.57 $1.62 Million - $2.27 Million	43,092 Added 161.68%	69,745 $2.83 Million
Q4 2022 Feb 10, 2023	BUY	$49.7 - $57.71 $204,366 - $237,303	4,112 Added 18.24%	26,653 $1.36 Million
Q3 2022 Nov 01, 2022	BUY	$53.86 - $66.8 $252,495 - $313,158	4,688 Added 26.26%	22,541 $1.21 Million
Q2 2022 Aug 03, 2022	BUY	$63.83 - $80.0 $371,426 - $465,520	5,819 Added 48.35%	17,853 $1.15 Million
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $403,846 - $470,059	5,255 Added 77.52%	12,034 $933,000
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $175,090 - $204,722	2,348 Added 52.99%	6,779 $582,000
Q3 2021 Nov 12, 2021	SELL	$73.77 - $83.61 $182,875 - $207,269	-2,479 Reduced 35.88%	4,431 $356,000
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $49,749 - $54,390	-618 Reduced 8.21%	6,910 $556,000
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $3.66 Million - $4.12 Million	-47,856 Reduced 86.41%	7,528 $635,000
Q4 2020 Feb 10, 2021	BUY	$75.39 - $82.36 $136,305 - $148,906	1,808 Added 3.37%	55,384 $4.44 Million
Q3 2020 Nov 13, 2020	SELL	$78.33 - $90.73 $1,566 - $1,814	-20 Reduced 0.04%	53,576 $4.31 Million
Q2 2020 Aug 11, 2020	BUY	$78.66 - $94.14 $523,324 - $626,313	6,653 Added 14.17%	53,596 $4.6 Million
Q1 2020 May 12, 2020	SELL	$71.57 - $93.3 $576,424 - $751,438	-8,054 Reduced 14.64%	46,943 $3.81 Million
Q4 2019 Feb 11, 2020	BUY	$76.7 - $88.45 $3.81 Million - $4.4 Million	49,712 Added 940.62%	54,997 $4.6 Million
Q3 2019 Nov 13, 2019	BUY	$81.4 - $89.78 $38,583 - $42,555	474 Added 9.85%	5,285 $462,000
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $6,462 - $7,252	88 Added 1.86%	4,811 $394,000
Q1 2019 May 14, 2019	SELL	$64.48 - $81.31 $52,809 - $66,592	-819 Reduced 14.78%	4,723 $384,000
Q4 2018 Feb 13, 2019	SELL	$61.45 - $77.8 $3,502 - $4,434	-57 Reduced 1.02%	5,542 $365,000
Q3 2018 Nov 13, 2018	BUY	$70.71 - $77.75 $10,040 - $11,040	142 Added 2.6%	5,599 $432,000
Q2 2018 Aug 01, 2018	SELL	$63.43 - $75.41 $34,188 - $40,645	-539 Reduced 8.99%	5,457 $403,000
Q1 2018 May 16, 2018	SELL	$62.56 - $72.26 $51,486 - $59,469	-823 Reduced 12.07%	5,996 $390,000
Q4 2017 Feb 13, 2018	BUY	$61.45 - $66.05 $17,451 - $18,758	284 Added 4.35%	6,819 $441,000
Q3 2017 Nov 08, 2017	BUY	$59.5 - $64.61 $18,207 - $19,770	306 Added 4.91%	6,535 $410,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,819 Added 1419.27%	6,229 $377,000
Q1 2017 Sep 15, 2017	BUY	N/A	33 Added 8.75%	410 $21,000
Q4 2016 Sep 15, 2017	SELL	N/A	-69 Reduced 15.47%	377 $17,000
Q2 2016 Sep 15, 2017	SELL	N/A	-11 Reduced 2.41%	446 $20,000
Q1 2016 Sep 15, 2017	SELL	N/A	-6,646 Reduced 93.57%	457 $19,000
Q4 2015 Sep 15, 2017	BUY	N/A	7,103	7,103 $271,000

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account